Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Single-Payer Healthcare
  • Federal Workers’ Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

WHAT'S NEW

  • Single-Payer Healthcare
  • Federal Workers' Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Jun 13 2023

Full Issue

Generic Drugmaker Indicates It May Back Out Of Making Opioid Payment

Financially troubled Mallinckrodt is due to make a $200 million payment this week as part of its pre-agreed $1.7 billion settlement, but may not do so, NPR reports. Meanwhile, the Washington Post covers a clash in Congress over fentanyl analogue overdoses.

NPR: Drug-Maker May Renege On $1.7 Billion Opioid Settlement 

The generic drug-maker Mallinckrodt says the company's board might not make a $200 million opioid settlement payment scheduled for later this week. In a June 5 filing with the Securities and Exchange Commission, the financially troubled firm said it faces growing questions internally and from creditors about the payout, which is part of a $1.7 billion opioid deal reached as part of a bankruptcy deal last year. (Mann, 6/12)

The Washington Post: Fentanyl Analogue Overdoses Spur Clash In Congress On Drug Classification 

Federal authorities in 2018 temporarily placed all substances related to fentanyl in a category reserved for the most dangerous controlled substances, an effort to stymie drug traffickers. Five years later, the number of overdose deaths linked to synthetic opioids is as high as ever, and critics say efforts to make the classification permanent will entrench harsh sentencing laws. With frustration mounting about the toll of fentanyl, the debate has sparked clashing political approaches. On Tuesday, Sen. Cory Booker (D-N.J.) plans to introduce legislation extending the temporary measure for up to two years for existing fentanyl-related substances and for up to four years when new analogues emerge. (Ovalle and Roubein, 6/13)

The Washington Post: Fentanyl Overdoses Took A Record Toll On The Army In Recent Years 

The parents of Sgt. 1st Class Ronald Conley Jr. want to know how many days their son lay dead on his bathroom floor from fentanyl poisoning without the Army noticing. Kue Vue’s brother questions how the straight-laced sergeant turned to drugs. Spec. Ari McGuire’s parents wonder why he wasn’t immediately sent to treatment when he suffered withdrawal symptoms in a training exercise. None of the families expect they will get all the answers about how the men died from fentanyl, a lethal synthetic opioid that has hit the Army the hardest among military branches and caused a record number of fatal overdoses among soldiers in 2021, the last complete year of data available, according to new figures obtained by The Washington Post. (Kornfield, Rempfer and Rich, 6/12)

Alaska Public Media: Counterfeit Pills With Fentanyl Flood Alaska’s Black Market 

Overdose deaths have been consistently rising in Alaska for the past several years. Most of that is due to illegal fentanyl. ... Coleman Cutchins is a lead pharmacist for the state health department. He said the risk profile of counterfeit pills is alarming. He said it’s not safe to take a pill that wasn’t prescribed for you. “Honestly, we’re at the point where the risk of somebody handing you a tablet that looks like a medication [if] you don’t know where it came from, is a very similar risk to somebody handing you a syringe with a needle on it and saying, ‘Inject this,’” said Cutchins. 

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 11
  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
  • Monday, May 4
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF